To Evaluate Compliance to Treatment Regimen (Rate of Deviations From the Prescribed Regimen) in Polish Females Treated With Different Low Dose Oral Contraceptives
Completed
- Conditions
- Contraception
- Interventions
- Drug: EE/DRSP (Yasmin Product Family)
- Registration Number
- NCT01198444
- Lead Sponsor
- Bayer
- Brief Summary
Adherence to the dosing scheme is the principal element of Combined Oral Contraceptives efficiency. On the other hand noncompliance seemed to be an inseparable element of any oral treatment. The aim of the study is to evaluate in everyday practice the relation between dosage errors and indicated factors, potentially influencing the compliance with the dosing scheme.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 11884
Inclusion Criteria
- Patients at the age of over 18 requiring contraception. The decisions would be made at the discretion of the attending physician.
Read More
Exclusion Criteria
- According to official Summary of Product Characteristics (SmPC) contraindications.
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Group 1 EE/DRSP (Yasmin Product Family) -
- Primary Outcome Measures
Name Time Method The percentage of users showing noncompliant behaviors 3 consecutive cycles
- Secondary Outcome Measures
Name Time Method The characteristics of noncompliant behavior 3 consecutive cycles The relation between noncompliant behavior and selected factors 3 consecutive cycles